As per the latest report by IMARC Group, the global neurostimulation devices market size reached US$ 5.5 Billion in 2019. Neurostimulation devices are medical instruments that generate electrical impulses to stimulate, modify, inhibit, regulate and alter the activity of the central, autonomous, and peripheral nervous systems in the patient’s body.

1. Copyright © IMARC Service Pvt Ltd. All Rights Reserved
Global Neurostimulation
Devices Market Research
and Upcoming Forecast
Report
Author: Elena Anderson,
Marketing Manager |
IMARC Group
© 2019 IMARC All Rights Reserved

2. Report Description
About IMARC Group
The International Market Analysis Research and Consulting Group is a leading adviser on
management strategy and market research worldwide. We partner with clients in all sectors
and regions to identify their highest-value opportunities, address their most critical
challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.

3. Report Description
Report Description and Highlights
GLOBAL Neurostimulation Devices Market Outlook:
According to the latest report by IMARC Group, titled “Neurostimulation Devices Market: Global
Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” the global
neurostimulation devices market size reached US$ 5.5 Billion in 2019.
Neurostimulation devices are medical instruments that generate electrical impulses to stimulate,
modify, inhibit, regulate and alter the activity of the central, autonomous, and peripheral nervous
systems in the patient’s body.
They have emerged as effective therapeutic solutions for treating various medical conditions, including
chronic pain, diabetic neuropathy, movement disorders, epilepsy and Parkinson's disease.
In recent years, electrical stimulation technologies have evolved that can deliver stimulation with a
higher spatial resolution to provide customized neuromodulation for optimal clinical outcomes.
Request Free Sample Report: https://www.imarcgroup.com/neurostimulation-devices-
market/requestsample

4. Report Description
Report Description and Highlights
Global Neurostimulation Devices Market Trends :
The rising prevalence of chronic pain ailments across the world has resulted in an escalating demand
for neurostimulation devices.
Besides this, the advancements made in neurotechnology and neuroimaging, coupled with the
increasing understanding of neurocircuitry has facilitated the development of advanced devices that
provide relief from several neurologic and psychiatric disorders.
Furthermore, rapid growth in the geriatric population, increasing healthcare expenditure, and the
rising preference for minimally invasive (MI) procedures among patients are some of the other factors
bolstering the growth of the market across the globe.
Looking forward, the market value is projected to reach a strong growth during the forecast period
(2021-2026).

5. Report Description
Report Description and Highlights
Market Summary:
Breakup by Stimulation Type:
• Internal
• External stimulation
Breakup By Device Type:
• Spinal cord stimulation (SCS)
• Deep brain stimulation (DBS)
• Dacral nerve stimulation (SNS)
• Vagus nerve stimulation (VNS)
• Gastric electrical stimulation (GES)
• Transcutaneous electrical nerve stimulation
• Transcranial magnetic stimulation
Breakup By End-use:
• Rehabilitation centers
• Hospitals
• Medical clinics

6. Breakup by Application:
• Pain management
• Epilepsy
• Essential tremors
• Urinary and fecal incontinence
• Depression
• Dystonia
• Parkinson’s disease
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Note: We are updating our research report 2021-2026. If you want to need latest primary and
secondary data with Cost Module, Business Strategy, Distribution Channel, etc.
Report Description
Report Description and Highlights

7. Competitive Landscape with Key Player:
• Biocontrol Medical Ltd.
• Boston Scientific Corporation
• Cyberonics Inc.
• Medtronic plc Neuronetics Inc.
• NeuroPace Inc.
• Neurosigma Inc.
• Nevro Corporation
• St. Jude Medical Inc. and Synapse Biomedical Inc.
View Full Customization Report with TOC and List of figure :
https://www.imarcgroup.com/neurostimulation-devices-market
Report Description
Report Description and Highlights

8. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

9. A partial List of our Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
Partial List of Clients

10. Report Description
Report Description and Highlights
© 2019 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of
International Market Analysis Research and Consulting (IMARC). No part of this publication may be
reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be
used in any form or by and means graphic electronic or mechanical, including photocopying, recording,
taping or by information storage or retrieval, or by any other form, without the express consent of
International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been
based on information and sources believed to be accurate and reliable at the time of publishing.
International Market Analysis Research and Consulting makes no representation of warranty of any kind as to
the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any
loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market
Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of
their respective companies.

11. FOR MORE DETAILS
Visit us at :
Stay With Us:
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com
https://www.imarcgroup.com
Contact Us